-+ 0.00%
-+ 0.00%
-+ 0.00%

Vanda Pharmaceuticals FY2026 Revenue expected to be more than $240.000M vs $248.797M Est

Benzinga·10/28/2026 20:05:06
Listen to the news
Vanda Pharmaceuticals (NASDAQ:VNDA) FY2026 Revenue expected to be more than $240.000M vs $248.797M Est